Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal CancerPeter S Hall, Pavel Bezecny, Russell Petty et al.|JAMA Oncology|2021Cited by 196
P3.13C.02 A Plasma Proteomics-Based Model for Clinical Benefit Prediction in Small Cell Lung Cancer Patients Receiving ImmunotherapyDavid R. Gandara, M.A. Schneider, David P. Carbone et al.|Journal of Thoracic Oncology|2024Cited by 0